Bessemer India Capital Holdings II Ltd. has fully exited Medi Assist Healthcare Services by divesting its remaining 15.67% stake in the company. The transaction, executed through open market transactions, involved the transfer of 1.1 crore shares at an average price of ₹522.70 apiece, amounting to ₹577.84 crore. Following the news of the block deal, shares of Medi Assist Healthcare Services experienced a surge, closing at ₹555.95 on the NSE, a 5.31% increase.
The shares offloaded by Bessemer India Capital were picked up by a consortium of prominent financial entities, including Citigroup Global Markets Mauritius, Goldman Sachs, and Morgan Stanley. Other notable investors included Kotak Mahindra Mutual Fund, Aditya Birla Sun Life MF, ICICI Prudential MF, Edelweiss MF, HDFC Mutual Fund, Wasatch Emerging India Fund, Public Sector Pension Investment Board and Canadian Crown Corp PSP Investments.
This marks the second significant stake reduction by Bessemer India Capital in Medi Assist Healthcare Services. In September 2024, the venture capital firm had already pared a 13.5% stake for ₹580 crore. With this recent transaction, Bessemer has completely exited its investment in the company.
Medi Assist Healthcare Services, incorporated in June 2000, operates as a health-tech and insurance-tech company. It primarily manages health benefits for employers, retail members, and public health schemes, acting as a third-party administrator (TPA) for insurance companies. The company provides services to insurance companies through its subsidiaries, including Medi Assist TPA, Medvantage TPA and Raksha TPA.
The company's services include health management, software subscriptions, software license services, and consultancy services pertaining to the healthcare and health insurance sectors. It also offers business support services and other technical services. Medi Assist plays an intermediary role between insurance companies and insured members, insurance companies and healthcare providers, and the government and beneficiaries of public health schemes.
In recent news, Medi Assist reported a 19% rise in net profit to ₹22.40 crore in Q1 FY2026, driven by improved EBITDA and a 13% increase in sales. The company's operating performance has strengthened with expanded margins and a 15% rise in PBDT year-on-year. In July 2025, Medi Assist Insurance TPA finalized its acquisition of Paramount Health Services & Insurance TPA, bringing an additional ₹4,000 crore in health premiums under administration.
As of August 12, 2025, the share price of Medi Assist Healthcare Services was ₹556.1 on both NSE and BSE. The stock's 52-week low was ₹400, while the 52-week high was ₹715.
The exit of Bessemer India Capital and the entry of new investors signal a potential shift in the company's growth trajectory. The company's strong financials and strategic acquisitions, like Paramount Health Services & Insurance TPA, could drive future expansion and market leadership.
